Interpace Biosciences (IDXG) Reports Q2 EPS of $0.01

Interpace Biosciences (OTC: IDXG) reported Q2 EPS of $0.01.Revenue for the quarter came in at $9.1 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• JPMorgan Double Downgrades Gulfport Energy (GPOR) to Underweight
• Erste Group Downgrades AXA SA (CS:FP) (AXAHY) to Hold
• Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch